Clinical Trial Update: Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and effectiveness of Low Molecular Weight Sulfated Dextran in islet transplantation after kidney transplantation for diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Low Molecular Weight Sulfated Dextran (low molecular weight sulfated dextran)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diabetes Mellitus, Type I | Phase 2 | Status: WITHDRAWN